Despoina Koulenti

ORCID: 0000-0003-4364-2612
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nosocomial Infections in ICU
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Resistance in Bacteria
  • Sepsis Diagnosis and Treatment
  • Respiratory Support and Mechanisms
  • Antifungal resistance and susceptibility
  • Bacterial Identification and Susceptibility Testing
  • Antimicrobial Resistance in Staphylococcus
  • Intensive Care Unit Cognitive Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Renal function and acid-base balance
  • Emergency and Acute Care Studies
  • Fungal Infections and Studies
  • Urinary Tract Infections Management
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Central Venous Catheters and Hemodialysis
  • Vibrio bacteria research studies
  • Mechanical Circulatory Support Devices
  • Pleural and Pulmonary Diseases
  • Patient Safety and Medication Errors
  • Infectious Diseases and Mycology
  • Clostridium difficile and Clostridium perfringens research
  • Healthcare Decision-Making and Restraints

The University of Queensland
2016-2025

King's College Hospital NHS Foundation Trust
2024-2025

University General Hospital Attikon
2015-2024

University of Osijek
2015-2023

European Society of Intensive Care Medicine
2013-2023

European Society of Clinical Microbiology and Infectious Diseases
2019-2023

National and Kapodistrian University of Athens
2007-2022

Sağlık Bilimleri Üniversitesi
2022

Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi
2022

University of Alberta
2022

Jason A. Roberts Sanjoy K. Paul Murat Akova Matteo Bassetti Jan J. De Waele and 95 more George Dimοpoulos Kirsi-Maija Kaukonen Despoina Koulenti Claudio M. Martin P. Montravers Jordi Rello Andrew Rhodes T. Starr S. C. Wallis Jeffrey Lipman Jason A. Roberts Jeffrey Lipman T. Starr Steven C. Wallis Sanjoy K. Paul A. S. Margarit Jan J. De Waele Luc De Crop Herbert Spapen Joost Wauters Thierry Dugernier Philippe G. Jorens I. Dapper Daniel De Backer Fabio Silvio Taccone Jordi Rello Laura Ruano Elsa Afonso Francisco Álvarez-Lerma M.P. Gracia-Arnillas Francisco Arnalich Nícolas de Albuquerque Pereira Feijóo N. Bardolet A Rovira Pau Garro Diego Colón C. Castillo J. Fernado María José López José Luís Fernández Alfredo Arribas J. L. Teja Elsa Ots Juan Carlos Montejo M. S. Catalán I. Prieto G. Gonzalo Beatriz Galván M. A. Blasco EC Meyer F. Del Nogal Loreto Vidaur Rafael Sebastián P. M. Garde M. d. M. Martin Velasco Rafael Zaragoza M. Esperatti A. Torres P. Montravers Olivier Baldési H. Dupont Yazine Mahjoub Sigismond Lasocki Jean-Michel Constantin Jean‐François Payen Claudio M. Martin J. Albanèse Yannick Mallédant Julien Pottecher Jean Yves Lefrant S. Jaber O. Joannes-Boyau Carmen Orban Marlies Ostermann Catherine McKenzie W. R. Berry Julie Smith K Lei Francesca Rubulotta Anthony Gordon Stephen J. Brett M. Stotz M. Templeton Andrew Rhodes Claudia Ebm Cristiane Aparecida Moran Kirsi-Maija Kaukonen Ville Pettilä George Dimοpoulos Despoina Koulenti A. Xristodoulou Vasiliki Theodorou Georgios Kouliatsis Eleni Sertaridou George Anthopoulos

Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam antibiotic dosing in achieves concentrations associated maximal activity affect patient outcome.This was prospective, multinational pharmacokinetic point-prevalence study including 8 antibiotics. Two blood samples were taken from each during single interval. The primary pharmacokinetic/pharmacodynamic targets free above the minimum inhibitory...

10.1093/cid/ciu027 article EN Clinical Infectious Diseases 2014-01-14

To describe the epidemiology of intra-abdominal infection in an international cohort ICU patients according to a new system that classifies cases setting acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized diffuse peritonitis), severity disease expression (infection, sepsis, septic shock). We performed multicenter (n = 309), observational, epidemiological study including adult diagnosed...

10.1007/s00134-019-05819-3 article EN cc-by-nc Intensive Care Medicine 2019-10-29

Objectives: Information on clinical practice regarding the diagnosis of pneumonia in European intensive care units is limited. The aim this study was to describe spectrum actual diagnostic practices a large sample units. Design: Prospective, observational, multicenter study. Setting: Twenty-seven nine countries. Patients: Consecutive patients requiring invasive mechanical ventilation for an admission or receiving >48 hrs irrespective diagnosis. Interventions: None. Measurements and Main...

10.1097/ccm.0b013e3181a037ac article EN Critical Care Medicine 2009-08-01

We investigated the epidemiology of ventilator-associated pneumonia in elderly ICU patients. More precisely, we assessed prevalence, risk factors, signs and symptoms, causative bacterial pathogens, associated outcomes.Secondary analysis a multicenter prospective cohort (EU-VAP project).Twenty-seven European ICUs.Patients who were mechanically ventilated for greater than or equal to 48 hours. compared middle-aged (45-64 yr; n = 670), old (65-74 549), very patients (≥ 75 n=...

10.1097/01.ccm.0000435665.07446.50 article EN Critical Care Medicine 2013-10-24

We utilized the database of Defining Antibiotic Levels in Intensive care unit patients (DALI) study to statistically compare pharmacokinetic/pharmacodynamic and clinical outcomes between prolonged-infusion intermittent-bolus dosing piperacillin/tazobactam meropenem critically ill using inclusion criteria similar those used previous prospective studies. This was a post hoc analysis prospective, multicentre pharmacokinetic point-prevalence (DALI), which recruited large cohort from 68 ICUs...

10.1093/jac/dkv288 article EN Journal of Antimicrobial Chemotherapy 2015-10-03

Abstract Introduction The objective of the study was to describe pharmacokinetics (PK) fluconazole, anidulafungin, and caspofungin in critically ill patients compare with previously published data. We also sought determine whether contemporary fluconazole doses achieved PK/pharmacodynamic (PD; PK/PD) targets this cohort intensive care unit patients. Methods Defining Antibiotic Levels Intensive (DALI) a prospective, multicenter point-prevalence PK study. Sixty-eight units across Europe...

10.1186/s13054-015-0758-3 article EN cc-by Critical Care 2015-01-28
Jean Chastre Bruno François Marc Bourgeois Apostolos Komnos Ricard Ferrer and 95 more Galia Rahav Nicolas De Schryver Alain Lepape İftihar Köksal Charles‐Édouard Luyt Miguel Sánchez García Antoní Torres Philippe Eggimann Despoina Koulenti Thomas L Holland Omar Ali Kathryn Shoemaker Pin Ren Julien Sauser Alexey Ruzin David E. Tabor Ahmad Akhgar Yuling Wu Yu Jiang Antonio DiGiandomenico Susan Colbert Drieke Vandamme Frank E. J. Coenjaerts Surbhi Malhotra‐Kumar Leen Timbermont Antonio Oliver Olivier Barraud Terramika Bellamy Marc J. M. Bonten Herman Goossens Colin Reisner Mark T. Esser Hasan S. Jafri Michael Joannidis Walter Klimscha Elisabeth De Waele Jacques Devriendt Vincent Huberlant Pieter Depuydt Sam Van Boxstael Mladen Perić Jasminka Kopić Michal Hanauer Tomas Hruby Vladimír Šrámek Petr Svoboda Tomáš Vymazal Martin Nováček Djillali Annane Jean‐Paul Mira Bertrand Souweine Pierre‐François Dequin Ferhat Meziani François Stéphan Saadalla Nseir Sébastien Gibot Carole Schwebel Gaëtan Plantefève Jean‐Luc Diehl Christian Richard Christian Lamer Kada Klouche Samir Jaber Epaminondas Zakynthinos Georgios Filntisis Spyros Zakynthinos Antonia Koutsoukou Georgios Saroglou Charikleia Nikolaou Glykeria Vlachogianni Ioannis Pnevmatikos Konstantinos Mandragos Ildikó Krémer Zsolt Dezso Rozgonyi Zsuzsa Marjanek Ignacio Martín‐Loeches Pierre Singer Vernon van Heerden Yehuda Carmeli Pedro Póvoa Antonio Alvarez Seoane Pedro Henrique de Moura Filipe Gonzalez Paula Ramírez Antonio Torres Martí Ricard Ferrer Lorena Oteiza D. Escudero Enrique Piacentini Paula Vera Luis Tamayo Miguel Angel Gonzalez Gallego B. Suberviola Cañas Iglesias Figueira Rafael Camino León

Abstract Background Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) preventing PA nosocomial was assessed PA-colonised mechanically ventilated subjects. Methods EVADE (NCT02696902) a phase 2, randomised, parallel-group, double-blind, placebo-controlled study Europe, Turkey, Israel, and USA. Subjects ≥ 18 years old, ventilated, tracheally...

10.1186/s13054-022-04204-9 article EN cc-by Critical Care 2022-11-15

The objectives of this study were to investigate the incidence candidemia, as well factors associated with Candida species distribution and fluconazole resistance, among patients admitted intensive care unit (ICU) during COVID-19 pandemic, compared two pre-pandemic periods. All ICU due from March 2020 October 2021, periods (2005-2008 2012-2015), who developed included. During period, candidemia was 10.2%, significantly higher 3.2% 4.2% in periods, respectively. proportion non-albicans...

10.3390/antibiotics11060771 article EN cc-by Antibiotics 2022-06-04
Andrew Conway Morris Katharina Köhler Thomas De Corte Ari Ercole Harm‐Jan de Grooth and 95 more Paul Elbers Pedro Póvoa Rui Morais Despoina Koulenti Sameer Jog Nathan D. Nielsen Alasdair Jubb Maurizio Cecconi Jan J. De Waele Marco Bezzi Alicia Gira Philipp Eller Tarikul Hamid Injamam Ull Haque Wim De Buyser Antonella Cudia Daniel De Backer Pierre Foulon Vincent Collin Jan J. De Waele Jolien Van Hecke Elisabeth De Waele Claire Van Malderen Jean-Baptiste Mesland Michaël Piagnerelli Lionel Haentjens Nicolas De Schryver Jan Van Leemput Philippe Vanhove Pierre Bulpa Viktoria Ilieva David Katz Anna Geagea Alexandra Binnie Fernando Tirapegui Gustavo Lago Jerónimo Graf Rodrigo Perez-Araos Patricio Vargas Felipe Martínez Eduardo Labarca Daniel Franco Daniela Parra-Tanoux Luis Felipe Reyes David Yepes Filip Periš Sanda Stojanović Stipić Cynthia Vanessa Campozano Burgos Paulo Roberto Navas Boada Jose Luis Barberan Brun Juan Pablo Paredes Ballesteros Ahmed Hammouda Omar Elmandouh Ahmed Y. Azzam Aliae Mohamed Hussein Islam Galal Ahmed K. Awad Mohammed A. Azab Maged Abdalla Hebatallah Hany Assal Mostafa Alfishawy Sherief Ghozy Samar Tharwat Abdullah Eldaly Veronika Reinhard Anne Chrisment Chrystelle Poyat Julio Badié Fernando Berdaguer Ferrari Björn Weiß Karl Friedrich Kuhn Julius J. Grunow Marco Lorenz Stefan J. Schaller Peter M. Spieth Marc Bota Falk Fichtner Kristina Fuest Tobias Lahmer Johannes Herrmann Patrick Meybohm Νικόλαος Μάρκου Georgia Vasileiadou Evangelia Chrysanthopoulou Panagiotis Papamichalis Ioanna Soultati Sameer Jog Kushal Kalvit Sheila Nainan Myatra Ivan Krupa Aisa Tharwat Alistair Nichol Aine McCarthy Ata Mahmoodpoor Tommaso Tonetti

The COVID-19 pandemic presented major challenges for critical care facilities worldwide. Infections which develop alongside or subsequent to viral pneumonitis are a challenge under sporadic and conditions; however, data have suggested that patterns of these differ between other pneumonitides. This secondary analysis aimed explore co-infection intensive unit-acquired infections (ICU-AI) the relationship use corticosteroids in large, international cohort critically ill patients.

10.1186/s13054-022-04108-8 article EN cc-by Critical Care 2022-08-03

Abstract Introduction Since positive blood cultures are uncommon in patients with nosocomial pneumonia (NP), the responsible pathogens usually isolated from respiratory samples. Studies on bacteremia associated hospital-acquired (HAP) have reported fatality rates of up to 50%. The purpose study is compare risk factors, and outcomes between bacteremic (B-NP) nonbacteremic (NB-NP) episodes. Methods This a prospective, observational multicenter (27 intensive care units nine European countries)....

10.1186/cc10036 article EN cc-by Critical Care 2011-02-16

Abstract Introduction The objective of this study was to describe the pharmacokinetics vancomycin in ICU patients and examine whether contemporary antibiotic dosing results concentrations that have been associated with favourable response. Methods Defining Antibiotic Levels Intensive Care (DALI) a prospective, multicentre pharmacokinetic point-prevalence study. as per treating clinician either by intermittent bolus or continuous infusion. Target trough concentration defined ≥15 mg/L target...

10.1186/cc13874 article EN cc-by Critical Care 2014-05-15
Coming Soon ...